Mary Douglas, PA
Medical · Traverse City, MINPI 1114928637
Payments from drug & device makers
Across 53 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$286
- Astellas Pharma US Inc$86
- Novo Nordisk$78
- AstraZeneca$55
- Bayer$46
- GSK$43
- plus $263 from 13 others
What the payments were for
- Food & beverage$856100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $286 |
| Astellas Pharma US Inc | 4 | $86 |
| Novo Nordisk | 5 | $78 |
| AstraZeneca | 4 | $55 |
| Bayer | 3 | $46 |
| GSK | 3 | $43 |
| Amgen | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Merck | 2 | $25 |
| Exact Sciences | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$856 in reported general payments places this provider in the 60th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 26 | $535 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $489 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $229 |
| Omeprazole | 14 | $201 |
| Cephalexin | 37 | $184 |
| Doxycycline Hyclate | 43 | $182 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $164 |
| Prednisone | 58 | $116 |
| Azithromycin | 32 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other medical in Traverse City
- Jesse KogelmanTraverse City$21K
- Kirsten SchmittTraverse City$10K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.